These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25729473)

  • 1. Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.
    Aigner E; Weiss G; Datz C
    World J Hepatol; 2015 Feb; 7(2):177-88. PubMed ID: 25729473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron overload and non-alcoholic fatty liver disease.
    Datz C; Müller E; Aigner E
    Minerva Endocrinol; 2017 Jun; 42(2):173-183. PubMed ID: 27834478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?
    Rametta R; Fracanzani AL; Fargion S; Dongiovanni P
    Curr Pharm Des; 2020; 26(10):1025-1035. PubMed ID: 32003680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron homeostasis in the metabolic syndrome.
    Datz C; Felder TK; Niederseer D; Aigner E
    Eur J Clin Invest; 2013 Feb; 43(2):215-24. PubMed ID: 23289518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
    Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
    BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity as an emerging risk factor for iron deficiency.
    Aigner E; Feldman A; Datz C
    Nutrients; 2014 Sep; 6(9):3587-600. PubMed ID: 25215659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation?
    Moris W; Verhaegh P; Jonkers D; Deursen CV; Koek G
    Semin Liver Dis; 2019 Nov; 39(4):476-482. PubMed ID: 31330553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive methods for iron overload evaluation in dysmetabolic patients.
    Branisso PPF; de Oliveira CPMS; Filho HML; Lima FR; Santos AS; Mancini MC; de Melo ME; Carrilho FJ; Rocha MS; Clark P; Branisso HJP; Cercato C
    Ann Hepatol; 2022; 27(4):100707. PubMed ID: 35477031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin resistance in dysmetabolic iron overload.
    Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
    Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical evaluation of the role of iron overload in fatty liver disease.
    Fernandez M; Lokan J; Leung C; Grigg A
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1873-1883. PubMed ID: 35906772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
    Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.
    Valenti L; Dongiovanni P; Fargion S
    World J Gastroenterol; 2012 Aug; 18(29):3782-6. PubMed ID: 22876027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.
    Corradini E; Buzzetti E; Dongiovanni P; Scarlini S; Caleffi A; Pelusi S; Bernardis I; Ventura P; Rametta R; Tenedini E; Tagliafico E; Fracanzani AL; Fargion S; Pietrangelo A; Valenti LV
    J Hepatol; 2021 Sep; 75(3):506-513. PubMed ID: 33774058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
    Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
    Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
    Stechemesser L; Eder SK; Wagner A; Patsch W; Feldman A; Strasser M; Auer S; Niederseer D; Huber-Schönauer U; Paulweber B; Zandanell S; Ruhaltinger S; Weghuber D; Haschke-Becher E; Grabmer C; Rohde E; Datz C; Felder TK; Aigner E
    Mol Metab; 2017 Jan; 6(1):38-47. PubMed ID: 28123936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron metabolism in Nonalcoholic Fatty Liver Disease.
    Nelson JE; Klintworth H; Kowdley KV
    Curr Gastroenterol Rep; 2012 Feb; 14(1):8-16. PubMed ID: 22124850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease.
    Murali AR; Gupta A; Brown K
    Hepatol Res; 2018 Feb; 48(3):E30-E41. PubMed ID: 28593739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.
    Chitturi S; George J
    Curr Gastroenterol Rep; 2003 Feb; 5(1):18-25. PubMed ID: 12530944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.